Johnson & Johnson (JNJ) Assets Average (2009 - 2026)
Johnson & Johnson recorded quarterly Assets Average of $200.1 billion in Q1 2026, up 2.06% quarter-over-quarter from $196.0 billion in Q4 2025, and up 7.04% year-over-year from $186.9 billion in Q1 2025.
Johnson & Johnson's Assets Average history runs 18 years deep, the most recent figure standing at $200.1 billion for Q1 2026.
- In Q1 2026, Assets Average rose 7.04% year-over-year to $200.1 billion; the TTM figure through Mar 2026 stood at $200.1 billion (up 7.04% YoY), while the FY2025 annual figure was $189.7 billion, up 9.1% from the prior year.
- Assets Average came in at $200.1 billion for Q1 2026 at Johnson & Johnson, up from $196.0 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $200.1 billion in Q1 2026 to a low of $166.8 billion in Q4 2023.
- A 5-year average of $183.5 billion and a median of $180.4 billion in 2022 frame the typical range for Assets Average.
- Across the five-year window, Assets Average fell 11.43% in 2024 and advanced 10.09% in 2025, its largest moves.
- Johnson & Johnson's Assets Average stood at $176.4 billion in 2022, then retreated by 5.45% to $166.8 billion in 2023, then increased by 7.43% to $179.2 billion in 2024, then gained by 9.39% to $196.0 billion in 2025, then gained by 2.06% to $200.1 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $200.1 billion, $196.0 billion, and $193.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 114.53 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 200.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 135.21 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 132.78 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 91.55 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 57.65 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 208.08 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 88.26 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | 314.07 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | 200.05 Bn |
| Dec 28, 2025 | 196.01 Bn |
| Sep 28, 2025 | 193.10 Bn |
| Jun 29, 2025 | 193.53 Bn |
| Mar 30, 2025 | 186.89 Bn |
| Dec 29, 2024 | 179.20 Bn |
| Sep 29, 2024 | 179.69 Bn |
| Jun 30, 2024 | 176.53 Bn |
| Mar 31, 2024 | 169.76 Bn |
| Dec 31, 2023 | 166.81 Bn |
| Oct 1, 2023 | 178.87 Bn |
| Jul 2, 2023 | 193.83 Bn |
| Apr 2, 2023 | 191.67 Bn |
| Jan 1, 2023 | 181.25 Bn |
| Oct 2, 2022 | 176.42 Bn |
| Jul 3, 2022 | 178.04 Bn |
| Apr 3, 2022 | 180.19 Bn |
| Jan 2, 2022 | 180.62 Bn |
| Oct 3, 2021 | 177.83 Bn |
| Jul 4, 2021 | 174.50 Bn |
| Apr 4, 2021 | 173.73 Bn |
| Jan 3, 2021 | 172.79 Bn |
| Sep 27, 2020 | 164.54 Bn |
| Jun 28, 2020 | 156.70 Bn |
| Mar 29, 2020 | 156.37 Bn |
| Dec 29, 2019 | 156.62 Bn |
| Sep 29, 2019 | 155.32 Bn |
| Jun 30, 2019 | 152.57 Bn |
| Mar 31, 2019 | 151.49 Bn |
| Dec 30, 2018 | 154.33 Bn |
| Sep 30, 2018 | 155.53 Bn |
| Jul 1, 2018 | 156.00 Bn |
| Apr 1, 2018 | 156.96 Bn |
| Dec 31, 2017 | 156.48 Bn |
| Oct 1, 2017 | 154.23 Bn |
| Jul 2, 2017 | 148.86 Bn |
| Apr 2, 2017 | 143.06 Bn |
| Jan 1, 2017 | 140.79 Bn |
| Oct 2, 2016 | 140.09 Bn |
| Jul 3, 2016 | 138.02 Bn |
| Apr 3, 2016 | 134.82 Bn |
| Jan 3, 2016 | 133.34 Bn |
| Sep 27, 2015 | 132.65 Bn |
| Jun 28, 2015 | 130.31 Bn |
| Mar 29, 2015 | 129.47 Bn |
| Dec 28, 2014 | 131.23 Bn |
| Sep 28, 2014 | 133.65 Bn |
| Jun 29, 2014 | 134.27 Bn |
| Mar 30, 2014 | 133.01 Bn |
| Dec 29, 2013 | 129.81 Bn |
| Sep 29, 2013 | 125.63 Bn |
| Jun 30, 2013 | 122.93 Bn |
| Mar 31, 2013 | 121.44 Bn |
| Dec 30, 2012 | 120.15 Bn |
| Sep 30, 2012 | 117.35 Bn |
| Jul 1, 2012 | 115.97 Bn |
| Apr 1, 2012 | 114.92 Bn |
| Jan 1, 2012 | 112.73 Bn |
| Oct 2, 2011 | 111.97 Bn |
| Jul 3, 2011 | 110.13 Bn |
| Apr 3, 2011 | 105.53 Bn |
| Jan 2, 2011 | 100.58 Bn |
| Oct 3, 2010 | 95.27 Bn |
| Jul 4, 2010 | 92.87 Bn |
| Apr 4, 2010 | 94.06 Bn |
| Jan 3, 2010 | 93.12 Bn |
| Sep 27, 2009 | 89.50 Bn |